PDE5A and metabolic disease: Together, these studies highlight the diverse mechanisms by which PDE5 inhibitors, including mirodenafil, sildenafil, and tadalafil, modulate autophagy, inflammation, and mitochondrial function, offering potential therapeutic avenues for neurodegenerative and metabolic diseases.